This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prindiville, S. A. Articles by Bunn, P. A. Search for Related Content PubMed PubMed Citation Articles by Prindiville, S. A. Articles by Bunn, P. A.

Sputum Cytological Atypia as a Predictor of Incident Lung Cancer in a Cohort of Heavy Smokers with Airflow Obstruction¹

Departments of Medicine [S. A. P., F. R. H., P. A. B., Y. E. M.], Preventive Medicine and Biostatistics [T. B., H. J. W., K. O. V., A. E. B., C. Z.], and Pathology [W. A. F., K. R. S.], School of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262; Denver Veterans Affairs Medical Center, Denver, Colorado 80220 [Y. E. M.]; and Lung Cancer Institute of Colorado, Denver, Colorado 80218 [T. C. K.]

Individuals with cytological atypia in sputum may be at increased risk for lung cancer. We conducted a longitudinal analysis of the association between lung cancer incidence and cytological atypia in sputum samples collected prospectively from an ongoing cohort of adults at high risk for lung cancer. Cohort members had a smoking history of 30 pack-years and chronic obstructive pulmonary disease documented by pulmonary airflow testing. Sputum samples collected at baseline and periodically thereafter were examined by standard cytological methods. From the cohort of 2006 people, there were 83 incident lung cancers over 4469 person-years of observation. At baseline, the association between personal and behavioral characteristics, and sputum cytological atypia was assessed by multiple logistic regression. The association between sputum cytological atypia and incident lung cancer was then assessed by hazard ratios using proportional hazards regression analysis, adjusting for potential confounding factors. Cytological atypia graded as moderate or worse was associated with continuing cigarette smoking (adjusted odds ratio, 2.5; 95% confidence interval, 1.5–4.1), and with lower levels of intake of fruits and vegetables (P for trend = 0.04). Atypia was not associated with several other factors, including the degree of airflow obstruction, the use of vitamin supplements, nonsteroidal anti-inflammatory drugs, or metered-dose steroid inhalers. Incident lung cancer was increased among those with moderate or worse cytological atypia (adjusted hazards ratio, 2.8; 95% confidence interval, 1.4–5.5). This association was not confounded by other risk factors. We conclude that in this high-risk cohort, cytological atypia is associated with continuing smoking and low intake of fruits and vegetables, but that independent of these and other factors, the risk of incident lung cancer is increased among those with moderate or worse grades of cytological atypia in their sputum.

This article has been cited by other articles:

				R. L. Keith Chemoprevention of Lung Cancer Proceedings of the ATS, April 15, 2009; 6(2): 187 - 193. [Abstract] [Full Text] [PDF]

				A. Punturieri, E. Szabo, T. L. Croxton, S. D. Shapiro, and S. M. Dubinett Lung Cancer and Chronic Obstructive Pulmonary Disease: Needs and Opportunities for Integrated Research J Natl Cancer Inst, April 15, 2009; 101(8): 554 - 559. [Abstract] [Full Text] [PDF]

				M. L. Cote, W. Yoo, A. S. Wenzlaff, G. M. Prysak, S. K. Santer, G. B. Claeys, A. L. Van Dyke, S. J. Land, and A. G. Schwartz Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women Carcinogenesis, April 1, 2009; 30(4): 626 - 635. [Abstract] [Full Text] [PDF]

				Y.-G. Fan, P. Hu, Y. Jiang, R.-S. Chang, S.-X. Yao, W. Wang, J. He, P. Prorok, and Y.-L. Qiao Association Between Sputum Atypia and Lung Cancer Risk in an Occupational Cohort in Yunnan, China Chest, March 1, 2009; 135(3): 778 - 785. [Abstract] [Full Text] [PDF]

				J. Chen, S. Lam, A. Pilon, A. McWilliams, C. MacAulay, and E. Szabo Higher Levels of the Anti-inflammatory Protein CC10 Are Associated with Improvement in Bronchial Dysplasia and Sputum Cytometric Assessment in Individuals at High Risk for Lung Cancer Clin. Cancer Res., March 1, 2008; 14(5): 1590 - 1597. [Abstract] [Full Text] [PDF]

				S. Jonsson, M. Varella-Garcia, Y. E. Miller, H. J. Wolf, T. Byers, S. Braudrick, P. Kiatsimkul, M. Lewis, T. C. Kennedy, R. L. Keith, et al. Chromosomal Aneusomy in Bronchial High-Grade Lesions Is Associated with Invasive Lung Cancer Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 342 - 347. [Abstract] [Full Text] [PDF]

				T. Byers, H. J. Wolf, W. A. Franklin, S. Braudrick, D. T. Merrick, K. R. Shroyer, F. R. Hirsch, C. Zeng, A. E. Baron, P. A. Bunn, et al. Sputum Cytologic Atypia Predicts Incident Lung Cancer: Defining Latency and Histologic Specificity Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 158 - 162. [Abstract] [Full Text] [PDF]

				G. T. Stathopoulos, T. P. Sherrill, D.-S. Cheng, R. M. Scoggins, W. Han, V. V. Polosukhin, L. Connelly, F. E. Yull, B. Fingleton, and T. S. Blackwell Epithelial NF-{kappa}B activation promotes urethane-induced lung carcinogenesis PNAS, November 20, 2007; 104(47): 18514 - 18519. [Abstract] [Full Text] [PDF]

				Y. E. Miller, P. Blatchford, D. S. Hyun, R. L. Keith, T. C. Kennedy, H. Wolf, T. Byers, P. A. Bunn Jr., M. T. Lewis, W. A. Franklin, et al. Bronchial Epithelial Ki-67 Index Is Related to Histology, Smoking, and Gender, but Not Lung Cancer or Chronic Obstructive Pulmonary Disease Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2425 - 2431. [Abstract] [Full Text] [PDF]

				R. L. Sedjo, T. Byers, E. Barrera Jr., C. Cohen, E. T. H. Fontham, L. A. Newman, C. D. Runowicz, A. G. Thorson, M. J. Thun, E. Ward, et al. A Midpoint Assessment of the American Cancer Society Challenge Goal to Decrease Cancer Incidence by 25% Between 1992 and 2015 CA Cancer J Clin, November 1, 2007; 57(6): 326 - 340. [Abstract] [Full Text] [PDF]

				J. Gray, J. T. Mao, E. Szabo, M. Kelley, J. Kurie, and G. Bepler Lung Cancer Chemoprevention: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 56S - 68S. [Abstract] [Full Text] [PDF]

				T. C. Kennedy, A. McWilliams, E. Edell, T. Sutedja, G. Downie, R. Yung, A. Gazdar, and P. N. Mathur Bronchial Intraepithelial Neoplasia/Early Central Airways Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 221S - 233S. [Abstract] [Full Text] [PDF]

				Y. E. Miller and R. L. Keith Inhaled Corticosteroids and Lung Cancer Chemoprevention Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 636 - 637. [Full Text] [PDF]

				G. Loewen, N. Natarajan, D. Tan, E. Nava, D. Klippenstein, M. Mahoney, M. Cummings, and M. Reid Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment Thorax, April 1, 2007; 62(4): 335 - 340. [Abstract] [Full Text] [PDF]

				G. J. Kelloff, S. M. Lippman, A. J. Dannenberg, C. C. Sigman, H. L. Pearce, B. J. Reid, E. Szabo, V. C. Jordan, M. R. Spitz, G. B. Mills, et al. Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer--A Plan to Move Forward Clin. Cancer Res., June 15, 2006; 12(12): 3661 - 3697. [Abstract] [Full Text] [PDF]

				D. Schottenfeld and J. Beebe-Dimmer Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin, March 1, 2006; 56(2): 69 - 83. [Abstract] [Full Text] [PDF]

				S. M. Jamshedur Rahman, Y. Shyr, P. B. Yildiz, A. L. Gonzalez, H. Li, X. Zhang, P. Chaurand, K. Yanagisawa, B. S. Slovis, R. F. Miller, et al. Proteomic Patterns of Preinvasive Bronchial Lesions Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1556 - 1562. [Abstract] [Full Text] [PDF]

				Y. E. Miller Pathogenesis of Lung Cancer: 100 Year Report Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 216 - 223. [Abstract] [Full Text] [PDF]

				F. R. Hirsch and S. M. Lippman Advances in the Biology of Lung Cancer Chemoprevention J. Clin. Oncol., May 10, 2005; 23(14): 3186 - 3197. [Abstract] [Full Text] [PDF]